Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica J Manson

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
The Lancet. Rheumatology|December 26, 2024
Dermatology response to the Hyperinflammation and HLH Across Specialty Collaboration consensus guideline - Authors' replyAisling S Carr, Ben Carpenter, Ian Proctor, et al.
Rheumatology (Oxford, England)|July 12, 2019
Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathiesMeredyth G Ll Wilkinson, Anna Radziszewska, Chris Wincup, et al.
Arthritis Research & Therapy|October 7, 2005
Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicityLesley J Mason, Anastasia Lambrianides, Joanna D Haley, et al.
Arthritis and Rheumatism|June 30, 2007
Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndromeAnastasia Lambrianides, Ian Giles, Yiannis Ioannou, et al.
Clinical Medicine (London, England)|May 18, 2022
Understanding the diagnosis and management of multisystem inflammatory syndrome in adults (MIS-A) in the UK: results of a national Delphi processLauren Hookham, Corinne Fisher, Jessica J Manson, et al.
The Journal of Infection|December 6, 2024
The association between rickettsial infection and hyperinflammation, diagnostic and management challengesSophie Skarbek, Thomas Ha Samuels, Sana Sharrack, et al.
Lupus Science & Medicine|November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulinJessica J Manson, Kevin Mills, Elizabeth Jury, et al.
Frontiers in Immunology|March 14, 2022
Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.
The Lancet. Respiratory Medicine|June 20, 2020
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunitiesPuja Mehta, Joanna C Porter, Jessica J Manson, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experienceAsim Khan, Alice Cole, Naveen Bhadauria, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Rheumatology|December 26, 2024
Dermatology response to the Hyperinflammation and HLH Across Specialty Collaboration consensus guideline - Authors' replyAisling S Carr, Ben Carpenter, Ian Proctor, et al.
Rheumatology (Oxford, England)|July 12, 2019
Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathiesMeredyth G Ll Wilkinson, Anna Radziszewska, Chris Wincup, et al.
Arthritis Research & Therapy|October 7, 2005
Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicityLesley J Mason, Anastasia Lambrianides, Joanna D Haley, et al.
Arthritis and Rheumatism|June 30, 2007
Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndromeAnastasia Lambrianides, Ian Giles, Yiannis Ioannou, et al.
Clinical Medicine (London, England)|May 18, 2022
Understanding the diagnosis and management of multisystem inflammatory syndrome in adults (MIS-A) in the UK: results of a national Delphi processLauren Hookham, Corinne Fisher, Jessica J Manson, et al.
The Journal of Infection|December 6, 2024
The association between rickettsial infection and hyperinflammation, diagnostic and management challengesSophie Skarbek, Thomas Ha Samuels, Sana Sharrack, et al.
Lupus Science & Medicine|November 15, 2014
Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulinJessica J Manson, Kevin Mills, Elizabeth Jury, et al.
Frontiers in Immunology|March 14, 2022
Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid ArthritisAudrey Paoletti, Bineta Ly, Samuel Bitoun, et al.
The Lancet. Respiratory Medicine|June 20, 2020
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunitiesPuja Mehta, Joanna C Porter, Jessica J Manson, et al.
Annals of the Rheumatic Diseases|August 1, 2020
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco <i>et al</i>. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experienceAsim Khan, Alice Cole, Naveen Bhadauria, et al.
Pageof 5